AAAAAA
Results: 1-25/49
Authors:
Oberg, K
Citation: K. Oberg, Chemotherapy and biotherapy in the treatment of neuroendocrine tumours, ANN ONCOL, 12, 2001, pp. S111-S114
Authors:
Granberg, D
Eriksson, B
Wilander, E
Grimfjard, P
Fjallskog, ML
Oberg, K
Skogseid, B
Citation: D. Granberg et al., Experience in treatment of metastatic pulmonary carcinoid tumors, ANN ONCOL, 12(10), 2001, pp. 1383-1391
Authors:
Ricke, J
Klose, KJ
Mignon, M
Oberg, K
Wiedenmann, B
Citation: J. Ricke et al., Standardisation of imaging in neuroendocrine tumours: results of a European delphi process, EUR J RAD, 37(1), 2001, pp. 8-17
Authors:
Oberg, K
Eliasson, B
Citation: K. Oberg et B. Eliasson, A method for screening of coverage and film thickness of monolayers by projection of molecular electron density surface onto a substrate plane, MATER LETT, 49(3-4), 2001, pp. 147-153
Authors:
Oberg, K
Berglund, A
Edlund, U
Eliasson, B
Citation: K. Oberg et al., Prediction of nonlinear optical responses of organic compounds, J CHEM INF, 41(3), 2001, pp. 811-814
Authors:
Oberg, K
Persson, P
Shchukarev, A
Eliasson, B
Citation: K. Oberg et al., Comparison of monolayer films of stearic acid and methyl stearate on an Al2O3 surface, THIN SOL FI, 397(1-2), 2001, pp. 102-108
Authors:
Zhou, YH
Wang, S
Gobl, A
Oberg, K
Citation: Yh. Zhou et al., Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors, ONCOL-BASEL, 60(4), 2001, pp. 330-338
Authors:
Toren, A
Oberg, K
Citation: A. Toren et K. Oberg, Change in twisted trunk postures by the use of saddle seats - a conceptualstudy, J AGR ENG R, 78(1), 2001, pp. 25-34
Authors:
Afargan, M
Janson, ET
Gelerman, G
Rosenfeld, R
Ziv, O
Karpov, O
Wolf, A
Bracha, M
Shohat, D
Liapakis, G
Gilon, C
Hoffman, A
Stephensky, D
Oberg, K
Citation: M. Afargan et al., Novel long-acting somatostatin analog with endocrine selectivity: Potent suppression of growth hormone but not of insulin, ENDOCRINOL, 142(1), 2001, pp. 477-486
Authors:
Oberg, K
Citation: K. Oberg, Established clinical use of octreotide and lanreotide in oncology, CHEMOTHERA, 47, 2001, pp. 40-53
Authors:
Stalberg, P
Lopez-Egido, JR
Wang, S
Gobl, A
Oberg, K
Skogseid, B
Citation: P. Stalberg et al., Differentially expressed cDNAs in PLC beta 3-induced tumor suppression in a human endocrine pancreatic tumor cell line: Activation of the human mismatch repair protein 3 gene, BIOC BIOP R, 281(1), 2001, pp. 227-231
Authors:
Oberg, K
Edlund, U
Eliasson, B
Shchukarev, A
Seshadri, K
Allara, D
Citation: K. Oberg et al., Spectroscopic characterization of the bonding, orientation, and coverage of copper tetraazaphthalocyanine monolayer films on SiO2 surfaces, J PHYS CH B, 104(45), 2000, pp. 10627-10634
Authors:
Oberg, K
Citation: K. Oberg, State of the art and future prospects in the management of neuroendocrine tumors, Q J NUCL M, 44(1), 2000, pp. 3-12
Authors:
Eriksson, B
Bergstrom, M
Orlefors, H
Sundin, A
Oberg, K
Langstrom, B
Citation: B. Eriksson et al., Use of PET in neuroendocrine tumors - In vivo applications and in vitro studies, Q J NUCL M, 44(1), 2000, pp. 68-76
Authors:
Portela-Gomes, GM
Stridsberg, M
Grimelius, L
Oberg, K
Janson, ET
Citation: Gm. Portela-gomes et al., Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas, APPL IMMUNO, 8(2), 2000, pp. 126-132
Authors:
Sundin, A
Eriksson, B
Bergstrom, M
Bjurling, P
Lindner, KJ
Oberg, K
Langstrom, B
Citation: A. Sundin et al., Demonstration of [C-11] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography, NUCL MED BI, 27(1), 2000, pp. 33-41
Authors:
Zhou, Y
Wang, S
Gobl, A
Oberg, K
Citation: Y. Zhou et al., The interferon-alpha regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors, ANN ONCOL, 11(6), 2000, pp. 707-714
Authors:
Imam, H
Eriksson, B
Oberg, K
Citation: H. Imam et al., Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours, ANN ONCOL, 11(3), 2000, pp. 295-300
Authors:
Khan, TS
Imam, H
Juhlin, C
Skogseid, B
Grondal, S
Tibblin, S
Wilander, E
Oberg, K
Eriksson, B
Citation: Ts. Khan et al., Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: Long-term survival in its adjuvant use, ANN ONCOL, 11(10), 2000, pp. 1281-1287
Authors:
Janson, ET
Westlin, JE
Ohrvall, U
Oberg, K
Lukinius, A
Citation: Et. Janson et al., Nuclear localization of In-111 after intravenous injection of [In-111-DTPA-D-Phe(1)]-octreotide in patients with neuroendocrine tumors, J NUCL MED, 41(9), 2000, pp. 1514-1518
Authors:
Cunningham, JL
Lopez-Egido, JR
Janson, ET
Eriksson, B
Oberg, K
Gobl, AE
Citation: Jl. Cunningham et al., Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed in human midgut carcinoids but is not detectable in normal enterochromaffin cells, J ENDOCR, 164(3), 2000, pp. 315-322
Authors:
Granberg, D
Wilander, E
Oberg, K
Skogseid, B
Citation: D. Granberg et al., Prognostic markers in patients with typical bronchial carcinoid tumors, J CLIN END, 85(9), 2000, pp. 3425-3430
Authors:
Wang, S
Lukinius, A
Zhou, YG
Stalberg, P
Gobl, A
Oberg, K
Skogseid, B
Citation: S. Wang et al., Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa, ENDOCRINOL, 141(7), 2000, pp. 2589-2593
Authors:
Oberg, K
Citation: K. Oberg, Role of somatostatin analogues in oncology, DIGESTION, 62, 2000, pp. 1-1
Authors:
Eriksson, B
Oberg, K
Stridsberg, M
Citation: B. Eriksson et al., Tumor markers in neuroendocrine tumors, DIGESTION, 62, 2000, pp. 33-38